# US 2026/0116858 A1 · Novel lappaconitine derivative and use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0116858 A1
- Document ID: US20260116858A1
- Status: Published application
- Kind: A1
- Application number: 19/427,612
- Filed: 2025-12-19
- Published: 2026-04-30
- Earliest claimed: 2020-03-09
- Assignees: Qgenetics Co., Ltd.
- Applicants: Qgenetics Co., Ltd.
- Inventors: Mun Seog CHANG; Tae Hee LEE; Ha Young KIM; Jung Bin MIN
- Web page: https://patentgrep.com/patent/US20260116858A1

## CPC

- C07D 221/22: Bridged ring systems
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

The present invention pertains to a novel lappaconitine derivative and a method for producing same.

## Claims

### Claim 1

A compound represented by the following Formula 1, and a stereoisomer, a hydrate, a solvate, or a pharmaceutically acceptable salt thereof:
wherein R1 and R2 are each independently selected from the group consisting of H, C1-10 alkyl, C2-10 alkenyl, C3-6 cycloalkyl, C4-6 cycloalkenyl, phenyl, aromatic heterocycle, —C(O)—R3, —C(O)—(CH2)n-R4, —C(S)—(CH2)n-R5, —C(O)—O—R6, —C(S)—O—(CH2)n-R7, —C(O)—N—R8R9, —S(O)n-R10 and —S(O)n-NR11R12;
wherein R3 is C1-10 alkyl, C2-10 alkenyl, C3-6 cycloalkyl, C4-6 cycloalkenyl, phenyl, or an aromatic heterocycle;
in —C(O)—(CH2)n-R4, wherein n is 1-3, and R4 is C1-10 alkyl, C2-10 alkenyl, C3-6 cycloalkyl, C4-6 cycloalkenyl, phenyl, or an aromatic heterocycle;
in —C(S)—(CH2)n-R5, wherein n is 1-3, and R5 is C1-10 alkyl, C2-10 alkenyl, C3-6 cycloalkyl, C4-6 cycloalkenyl, phenyl, or an aromatic heterocycle;
wherein R6 is C1-10 alkyl, C2-10 alkenyl, C3-6 cycloalkyl, C4-6 cycloalkenyl, phenyl, or an aromatic heterocycle;
in —C(S)—O—(CH2)n-R7, wherein n is 1-3, and R7 is C1-10 alkyl, C2-10 alkenyl, C3-6 cycloalkyl, C4-6 cycloalkenyl, phenyl, or an aromatic heterocycle;
wherein R8 and R9 are each independently H, C1-10 alkyl, C2-10 alkenyl, C3-6 cycloalkyl, C4-6 cycloalkenyl, phenyl, or an aromatic heterocycle;
in —S(O)n-R10, wherein n is 1 or 2, and R10 is H, C1-10 alkyl, C2-10 alkenyl, C3-6 cycloalkyl, C4-6 cycloalkenyl, phenyl, or an aromatic heterocycle; and
in —S(O)n-NR11R12, wherein n is 1 or 2, and R11 and R12 are each independently H, C1-10 alkyl, C2-10 alkenyl, C3-6 cycloalkyl, C4-6 cycloalkenyl, phenyl, or an aromatic heterocycle.

### Claim 2 (depends on 1)

The compound represented by the following Formula 1, and a stereoisomer, a hydrate, a solvate, or a pharmaceutically acceptable salt as claimed in claim 1, wherein R1 and R2 are each independently hydrogen.

### Claim 3 (depends on 1)

A method of synthesizing the compound of claim 1, comprising:
(a) allowing lappaconitine to react with an oxidizing agent; and
(b) allowing the reaction product of (a) to react with an organic solvent in the presence of a base.

### Claim 4 (depends on 3)

The method of claim 3, wherein the oxidizing agent of (a) is selected from the group consisting of phenyliodine diacetate PhI(OAc)2, lead (II) acetate [Pb(CH3CO2)2], lead (IV) acetate [Pb(CH3CO2)4], ozone, and HIO4.

### Claim 5 (depends on 3)

The method of claim 3, wherein the base of (b) is selected from the group consisting of sodium hydroxide, potassium carbonate, sodium carbonate, cesium carbonate, and potassium hydroxide.

### Claim 6 (depends on 3)

The method of claim 3, wherein the organic solvent of (b) is an aliphatic alcohol or an alkoxy alcohol.
